W E Martin, J A Resch, A B Baker. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » AdultAge FactorsAgedDiagnosis, DifferentialDihydroxyphenylalanine/therapeutic useDopamine/metabolismHumansMaleMetabolism, Inborn Errors/complicationsMixed Function Oxygenases/metabolismParkinson Disease/classificationParkinson Disease/diagnosisParkinson Disease/drug therapyParkinson Disease/enzymologyParkinson Disease/etiologyParkinson Disease/geneticsParkinson Disease, Secondary/chemically inducedPedigreeSpasm/etiologyTranquilizing Agents/adverse effectsTremor/diagnosisTyrosineTyrosine 3-Monooxygenase/metabolism
Substances： See more » Tranquilizing AgentsTyrosineDihydroxyphenylalanineMixed Function OxygenasesTyrosine 3-MonooxygenaseDopamine
Year: 1971 PMID： 4398909 DOI： 10.1001/archneur.1971.00490060028003
Source DB: PubMed Journal: Arch Neurol ISSN： 0003-9942